SecBot SecBot
Insider Cluster (1 insider) ·Filed Feb 25, 2026

QURE

uniQure N.V.
NEUTRAL
Impact 3/10
Horizondays Processed8mo ago
Insider cluster: 3 insiders, $0.5M total
Actionable Insight • Neutral

Monitor for additional insider selling, especially if it accelerates ahead of earnings or clinical trial readouts. This single transaction is not a signal on its own.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$24.87
T+0 close · Feb 24, 2026 · via day close
Latest settled
−1.09%
T+60 · $24.60
Vs SPY
−8.04%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 25 $24.87entry
  2. T+1 · 9mo ago −31.18%α −30.64% · $17.12
  3. T+5 · 9mo ago −63.65%α −62.55% · $9.04
  4. T+20 · 8mo ago −34.22%α −28.98% · $16.36
  5. T+60 · 6mo ago −1.09%α −8.04% · $24.60
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Chief Medical Officer Walid Abi-Saab sold 1,660 shares of QURE in the open market for $16,517. This is a small, routine transaction and consistent with recent insider selling patterns.

Key Financial Metrics

Direction
selling
Total Value
$16.5K
Insiders
1

Key Facts

  • Walid Abi-Saab, Chief Medical Officer, sold 1,660 shares at $9.95 per share
  • Total transaction value: $16,517
  • This was an open-market sale (Form 4 code 'S')
  • No other insider transactions in the past 7 days
  • Recent 30-day trend shows 3 sells totaling $460K

Financial Impact

$16,517 in open-market sales by a C-suite executive

insider ownershipshare count

Risk Factors

  • Potential perception of lack of confidence if selling continues ahead of key catalysts
  • Biotech volatility tied to clinical development risks

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (1 trades, 7d window)cluster-QURE-1772659818321

Track record

38 reports on QURE

Performance horizon

6 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +27.15% at T+20 after the Jul 29, 2026 report. 8 of 11 went positive at some point.

Filters
  1. Nov 6, 202610d ago 144 Neutral 2/10 Entry $22.79 to $22.71 Now $21.88 −3.99% ▼ −0.35% +0.02% vs SPY
  2. Nov 4, 202612d ago 8-K Bullish 7/10 No price data
  3. Nov 4, 202612d ago Press Release Neutral 6/10 Entry $23.03 to $21.01 Now $21.88 −4.99% ▼ −8.77% −4.36% vs SPY
  4. Nov 2, 202614d ago 8-K Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
  5. Nov 2, 202614d ago Press Release Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
  6. Oct 16, 20264w ago SC 13G/A Neutral 3/10 Entry $21.78 to $22.20 Now $21.88 +0.46% ▲ +1.93% +1.51% vs SPY
  7. Sep 2, 202610w ago 8-K Bullish 7/10 Entry $46.23 to $44.86 Now $21.88 −52.67% ▼ −2.96% −4.01% vs SPY
  8. Jul 29, 202615w ago 8-K Bullish 8/10 Entry $40.07 to $42.19 Now $21.88 −45.40% ▲ +5.29% +3.61% vs SPY
  9. Jul 7, 202619w ago Insider Cluster Bearish 5/10 Entry $41.41 to $43.49 Now $21.88 +47.16% ▼ −5.02% −5.33% vs SPY
  10. Jul 2, 202619w ago Insider Cluster Bearish 4/10 Entry $41.81 to $41.36 Now $21.88 +47.67% ▲ +1.08% +1.95% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens in 8h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 4, 2026